Command Palette

Search for a command to run...

Gennex Laboratories Ltd.
12.15(-0.33%)
1W: +9.03%

Gennex Laboratories Peer Comparison

Snapshot Summary

Gennex Laboratories Ltd. shows promising growth metrics and a favorable debt-to-equity ratio compared to its peers. However, while it maintains competitive profitability, it lags behind in certain efficiency ratios, making it a solid contender in the Pharmaceuticals & Drugs industry. Companies like Dr. Reddy's Laboratories and Cipla stand out as strong overall performers due to their robust profitability and lower valuations.

  • Gennex has a strong revenue growth rate of 32.18% YoY.
  • Dr. Reddy's Laboratories and Cipla exhibit the highest ROE and ROA metrics.
  • Cipla presents the best valuation attractiveness with a low PE and PEG ratio.
  • Divi's Laboratories shows concerning growth metrics, indicating potential financial weakness.
  • Dr. Reddy's Laboratories Ltd.: Highest ROE (21.76%) and strong EPS growth (68.07).
  • Cipla Ltd.: Competitive PE and PEG ratios with solid profitability.
  • Mankind Pharma Ltd.: High revenue growth and solid profitability metrics.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
Gennex Laboratories Ltd.₹11.94₹271.57Cr20.3213.64%0.12
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.